Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronen Brenner

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Autoimmunity Reviews|April 10, 2018
Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitorsMilena Tocut, Ronen Brenner, Gisele Zandman-Goddard
JAAD Case Reports|August 8, 2025
Merkel cell carcinoma originating in the gluteal regionShlomit Fennig, Yosef Landman, Ronen Brenner, et al.
Cancer Medicine|February 7, 2022
Merkel cell carcinoma in lymph nodes with and without primary originShlomit Fennig, Yosef Landman, Ronen Brenner, et al.
Cancer Control : Journal of the Moffitt Cancer Center|September 19, 2023
Comparative Analysis of First-Line FOLFOX Treatment With and Without Anti-VEGF Therapy in Metastatic Colorectal Carcinoma: A Real-World Data StudyRonen Brenner, Shlomit Amar-Farkash, Avital Klein-Brill, et al.
Biomedicines|June 2, 2021
Treatment of Rare Mutations in Patients with Lung CancerTarek Taha, Rasha Khoury, Ronen Brenner, et al.
Anti-Cancer Drugs|January 14, 2012
The combination of docetaxel, cisplatin, and 5-fluorouracil in advanced gastric cancer: a single-institution experienceIrit Ben Aharon, Ofer Purim, Yulia Kundel, et al.
Mayo Clinic Proceedings|July 6, 2019
Association of Bezafibrate Treatment With Reduced Risk of Cancer in Patients With Coronary Artery DiseaseZaza Iakobishvili, Tal Hasin, Robert Klempfner, et al.
BJC Reports|November 8, 2024
Comparative efficacy of combined CTLA-4 and PD-1 blockade vs. PD-1 monotherapy in metastatic melanoma: a real-world studyAvital Klein-Brill, Shlomit Amar-Farkash, Keren Rosenberg-Katz, et al.
Diseases of the Colon and Rectum|December 24, 2010
Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option?Yulia Kundel, Ronen Brenner, Ofer Purim, et al.
European Journal of Internal Medicine|August 23, 2016
Metabolic syndrome, obesity, and the risk of cancer developmentRafael Bitzur, Ronen Brenner, Elad Maor, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Autoimmunity Reviews|April 10, 2018
Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitorsMilena Tocut, Ronen Brenner, Gisele Zandman-Goddard
JAAD Case Reports|August 8, 2025
Merkel cell carcinoma originating in the gluteal regionShlomit Fennig, Yosef Landman, Ronen Brenner, et al.
Cancer Medicine|February 7, 2022
Merkel cell carcinoma in lymph nodes with and without primary originShlomit Fennig, Yosef Landman, Ronen Brenner, et al.
Cancer Control : Journal of the Moffitt Cancer Center|September 19, 2023
Comparative Analysis of First-Line FOLFOX Treatment With and Without Anti-VEGF Therapy in Metastatic Colorectal Carcinoma: A Real-World Data StudyRonen Brenner, Shlomit Amar-Farkash, Avital Klein-Brill, et al.
Biomedicines|June 2, 2021
Treatment of Rare Mutations in Patients with Lung CancerTarek Taha, Rasha Khoury, Ronen Brenner, et al.
Anti-Cancer Drugs|January 14, 2012
The combination of docetaxel, cisplatin, and 5-fluorouracil in advanced gastric cancer: a single-institution experienceIrit Ben Aharon, Ofer Purim, Yulia Kundel, et al.
Mayo Clinic Proceedings|July 6, 2019
Association of Bezafibrate Treatment With Reduced Risk of Cancer in Patients With Coronary Artery DiseaseZaza Iakobishvili, Tal Hasin, Robert Klempfner, et al.
BJC Reports|November 8, 2024
Comparative efficacy of combined CTLA-4 and PD-1 blockade vs. PD-1 monotherapy in metastatic melanoma: a real-world studyAvital Klein-Brill, Shlomit Amar-Farkash, Keren Rosenberg-Katz, et al.
Diseases of the Colon and Rectum|December 24, 2010
Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option?Yulia Kundel, Ronen Brenner, Ofer Purim, et al.
European Journal of Internal Medicine|August 23, 2016
Metabolic syndrome, obesity, and the risk of cancer developmentRafael Bitzur, Ronen Brenner, Elad Maor, et al.
Pageof 6